Literature DB >> 283421

Systemic bacillus Calmette-Guérin (BCG) activates natural suppressor cells.

J A Bennett, V S Rao, M S Mitchell.   

Abstract

Addition of normal C57BL/6 mouse bone marrow cells to an in vitro culture of normal C57BL/6 spleen cells and allogeneic P815-Y tumor cells inhibited the development of cell-mediated immunity. Bacillus Calmette-Guérin (BCG) enhanced the suppressive activity of these bone marrow cells as early as 2 days after its intravenous administration to donor mice and elicited similar activity in the spleen by 7 days. Concomitant with the appearance of suppressor cells in the spleen there was a decrease in bone cell number and an increase in spleen cell number. While normal spleen cells failed to inhibit immunization, spleen cells from thymectomized, irradiated, bone marrow-reconstituted mice were inhibitory. Administration of BCG further increased the suppressive activity of spleen cells in these T cell-deprived mice. From this evidence it appears that systemic administration of BCG activates natural suppressor cells in the bone marrow and elicits suppressor cells in the spleen through the migration and colonization of the spleen by bone marrow elements.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 283421      PMCID: PMC336280          DOI: 10.1073/pnas.75.10.5142

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  11 in total

1.  Activation of lymphoid cells by BCG in vitro.

Authors:  M B Mokyr; M S Mitchell
Journal:  Cell Immunol       Date:  1975-02       Impact factor: 4.868

2.  BCG-induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generation in vitro.

Authors:  G R Klimpel; C S Henney
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

3.  Separation of T and B lymphocytes by nylon wool columns: evaluation of efficacy by functional assays in vivo.

Authors:  D Trizio; G Cudkowicz
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

4.  Antibody-inhibiting activity of bone marrow cells in vitro.

Authors:  S K Singhal; S King; P J Drury
Journal:  Int Arch Allergy Appl Immunol       Date:  1972

5.  Immunopotentiation with BCG. I. Immune response to different strains and preparations.

Authors:  G B Mackaness; D J Auclair; P H Lagrange
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

6.  On the mode of action of BCG.

Authors:  M S Mitchell; D Kirkpatrick; M B Mokyr; I Gery
Journal:  Nat New Biol       Date:  1973-06-13

7.  Tumor cytotoxicity in vitro by macrophages from mice infected with mycobacterium bovis strain BCG.

Authors:  R P Cleveland; M S Meltzer; B Zbar
Journal:  J Natl Cancer Inst       Date:  1974-06       Impact factor: 13.506

8.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

9.  Immunosuppressive effects of methylglyoxal-bis(guanylhydrazone) on mouse bone marrow and spleen cells and their antagonism by spermidine.

Authors:  J Bennett; J Ehrke; P Fadale; C Dave; E Mihich
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

10.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

View more
  34 in total

1.  The effect of immunosuppressive drug cyclosporine A on myeloid-derived suppressor cells in transplanted mice.

Authors:  Chenlu Han; Tingting Wu; Ning Na; Yang Zhao; Weiguo Li; Yong Zhao
Journal:  Inflamm Res       Date:  2016-05-04       Impact factor: 4.575

Review 2.  Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus.

Authors:  Anca Dorhoi; Leigh A Kotzé; Jay A Berzofsky; Yongjun Sui; Dmitry I Gabrilovich; Ankita Garg; Richard Hafner; Shabaana A Khader; Ulrich E Schaible; Stefan He Kaufmann; Gerhard Walzl; Manfred B Lutz; Robert N Mahon; Suzanne Ostrand-Rosenberg; William Bishai; Nelita du Plessis
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

3.  Inhibition of mitogenesis induced by phytohemagglutinin and Lens culinaris lectin in adherent-cell supernatants treated with protein extract of Mycobacterium tuberculosis.

Authors:  C Parra; L F Montaño; M Huesca; I Rayón; K Willms; F Goodsaid
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

4.  Immunosuppressive activity of BCG: effects of adjuvant disease, lymphocyte subpopulations, and homing of thoracic duct cells in rats.

Authors:  R I Sutherland; M A Spadaro-Antonelli; V J Lawrence; F Quagliata
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

5.  Immunogenicity of viable tumor cells. A comparison of xenogenized tumor cells and BCG-tumor cell mixtures.

Authors:  Y Suzuki; K Suzuki; M Hosokawa; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

6.  Immune response to atypical mycobacteria: immunocompetence of heavily infected mice measured in vivo fails to substantiate immunosuppression data obtained in vitro.

Authors:  I M Orme; F M Collins
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

7.  Active suppression masks an underlying enhancement of antibody production in vitro by spleen cells from BCG-infected mice.

Authors:  C A Brown; I N Brown; V S Sljivić
Journal:  Immunology       Date:  1980-07       Impact factor: 7.397

Review 8.  Immature myeloid cells in the tumor microenvironment: Implications for immunotherapy.

Authors:  Neha Kamran; Mayuri Chandran; Pedro R Lowenstein; Maria G Castro
Journal:  Clin Immunol       Date:  2016-10-21       Impact factor: 3.969

Review 9.  The immunobiology of myeloid-derived suppressor cells in cancer.

Authors:  Morteza Motallebnezhad; Farhad Jadidi-Niaragh; Elmira Safaie Qamsari; Salman Bagheri; Tohid Gharibi; Mehdi Yousefi
Journal:  Tumour Biol       Date:  2015-11-26

Review 10.  Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages.

Authors:  Stefano Ugel; Francesco De Sanctis; Susanna Mandruzzato; Vincenzo Bronte
Journal:  J Clin Invest       Date:  2015-09-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.